FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204388384> ?p ?o ?g. }

• W3204388384 abstract "Abstract Background Fatigue is common in patents with breast cancer (BC), and can occur in patients with early stage disease and in the absence of muscle wasting (i.e. cachexia). We have reported transcriptional and proteomic alterations in muscles from BC patients, which are associated with fatigue. Mice implanted with human BC xenografts recapitulate the muscle molecular composition changes seen in patients, coupled with a greater rate of contraction-induced fatigue. Multiple bioinformatics platforms in both human and mouse muscles have identified peroxisome proliferator activated receptor gamma (PPARG) as central to this phenotype, with multiple PPARG target genes downregulated in response to tumor growth. The current study tested the hypothesis that the PPARG agonist pioglitazone (pio), a commonly prescribed diabetes drug, would rescue the transcriptional alterations observed in muscles of tumor-bearing mice. Methods Sixteen female NSG mice were implanted with breast cancer patient-derived orthotopic xenografts (BC-PDOX) via transplantation of Her 2 /neu + human tumor fragments. BC-PDOX mice were randomly assigned to a treatment group that received daily oral pio at 30 mg.kg -1 (n=8), or a control group that received a similar volume of vehicle (n=8). Treatment was initiated when tumors reached a volume of 600mm 3 , and lasted for 2-weeks. Hindlimb muscles were isolated from BC-PDOX and non-tumor bearing mice for RNA-sequencing, gene expression validation, and ATP quantification. Differentially expressed genes (DEGs) in muscles from BC-PDOX mice relative to non-tumor bearing controls were identified using DESeq2, and multiple bioinformatics platforms were employed to contextualize the DEGs. Results We found that the administration of pio restored the muscle gene expression patterns of BC-PDOX mice to a profile resembling muscles of non-tumor bearing NSG control mice. Validation of skeletal muscle gene expression by qPCR confirmed pio increased the expression of PPARG target genes in skeletal muscles. Isolated mitochondria from muscles of BC-PDOX mice treated with pio contained greater levels of ATP. There were no differences in body weights, muscle weights, or tumor volumes in pio vs. vehicle treated BC-PDOX mice. Conclusions These data demonstrate that oral pio supplementation rescues the BC-associated downregulation of PPARG target genes in skeletal muscle. Additionally, muscles from BC-PDOX mice treated with pio had greater levels of ATP, which would be associated a more fatigue-resistant muscle phenotype. Therefore, we propose that the FDA-approved and generic diabetes drug, pio, be considered as a supportive therapy for the treatment of BC-associated muscle fatigue." @default.
• W3204388384 created "2021-10-11" @default.
• W3204388384 creator A5019025372 @default.
• W3204388384 creator A5040132180 @default.
• W3204388384 creator A5050913678 @default.
• W3204388384 creator A5059468684 @default.
• W3204388384 creator A5078590780 @default.
• W3204388384 creator A5089902930 @default.
• W3204388384 date "2021-10-04" @default.
• W3204388384 modified "2023-09-24" @default.
• W3204388384 title "Pioglitazone administration restores a PPARG-dependent transcriptional network and ATP levels within skeletal muscles of mice implanted with patient-derived breast tumors" @default.
• W3204388384 cites W1800061482 @default.
• W3204388384 cites W1940235639 @default.
• W3204388384 cites W1964564264 @default.
• W3204388384 cites W1965041525 @default.
• W3204388384 cites W1973767788 @default.
• W3204388384 cites W1975796727 @default.
• W3204388384 cites W1977800385 @default.
• W3204388384 cites W1986087153 @default.
• W3204388384 cites W1994971530 @default.
• W3204388384 cites W2003064100 @default.
• W3204388384 cites W2009145663 @default.
• W3204388384 cites W2017379833 @default.
• W3204388384 cites W2023075736 @default.
• W3204388384 cites W2033204507 @default.
• W3204388384 cites W2045984402 @default.
• W3204388384 cites W2056630682 @default.
• W3204388384 cites W2056846940 @default.
• W3204388384 cites W2060702365 @default.
• W3204388384 cites W2070050178 @default.
• W3204388384 cites W2086199722 @default.
• W3204388384 cites W2091917093 @default.
• W3204388384 cites W2119968490 @default.
• W3204388384 cites W2121705930 @default.
• W3204388384 cites W2121828573 @default.
• W3204388384 cites W2130410032 @default.
• W3204388384 cites W2133992379 @default.
• W3204388384 cites W2142187664 @default.
• W3204388384 cites W2145280166 @default.
• W3204388384 cites W2162098634 @default.
• W3204388384 cites W2163791529 @default.
• W3204388384 cites W2168086498 @default.
• W3204388384 cites W2170670590 @default.
• W3204388384 cites W2173990401 @default.
• W3204388384 cites W2179438025 @default.
• W3204388384 cites W2197124664 @default.
• W3204388384 cites W2315900429 @default.
• W3204388384 cites W2345356016 @default.
• W3204388384 cites W2432815617 @default.
• W3204388384 cites W2592811885 @default.
• W3204388384 cites W2784374589 @default.
• W3204388384 cites W2795298113 @default.
• W3204388384 cites W2797783284 @default.
• W3204388384 cites W2897805491 @default.
• W3204388384 cites W2903811218 @default.
• W3204388384 cites W2948285744 @default.
• W3204388384 cites W3093593152 @default.
• W3204388384 cites W3096054453 @default.
• W3204388384 cites W3119042313 @default.
• W3204388384 cites W4234157358 @default.
• W3204388384 doi "https://doi.org/10.1101/2021.10.04.463044" @default.
• W3204388384 hasPublicationYear "2021" @default.
• W3204388384 type Work @default.
• W3204388384 sameAs 3204388384 @default.
• W3204388384 citedByCount "0" @default.
• W3204388384 crossrefType "posted-content" @default.
• W3204388384 hasAuthorship W3204388384A5019025372 @default.
• W3204388384 hasAuthorship W3204388384A5040132180 @default.
• W3204388384 hasAuthorship W3204388384A5050913678 @default.
• W3204388384 hasAuthorship W3204388384A5059468684 @default.
• W3204388384 hasAuthorship W3204388384A5078590780 @default.
• W3204388384 hasAuthorship W3204388384A5089902930 @default.
• W3204388384 hasBestOaLocation W32043883841 @default.
• W3204388384 hasConcept C121608353 @default.
• W3204388384 hasConcept C126322002 @default.
• W3204388384 hasConcept C130241916 @default.
• W3204388384 hasConcept C134018914 @default.
• W3204388384 hasConcept C143998085 @default.
• W3204388384 hasConcept C170493617 @default.
• W3204388384 hasConcept C187345961 @default.
• W3204388384 hasConcept C2777180221 @default.
• W3204388384 hasConcept C2778384471 @default.
• W3204388384 hasConcept C2778938600 @default.
• W3204388384 hasConcept C502942594 @default.
• W3204388384 hasConcept C530470458 @default.
• W3204388384 hasConcept C555293320 @default.
• W3204388384 hasConcept C71924100 @default.
• W3204388384 hasConcept C86803240 @default.
• W3204388384 hasConceptScore W3204388384C121608353 @default.
• W3204388384 hasConceptScore W3204388384C126322002 @default.
• W3204388384 hasConceptScore W3204388384C130241916 @default.
• W3204388384 hasConceptScore W3204388384C134018914 @default.
• W3204388384 hasConceptScore W3204388384C143998085 @default.
• W3204388384 hasConceptScore W3204388384C170493617 @default.
• W3204388384 hasConceptScore W3204388384C187345961 @default.
• W3204388384 hasConceptScore W3204388384C2777180221 @default.
• W3204388384 hasConceptScore W3204388384C2778384471 @default.
• W3204388384 hasConceptScore W3204388384C2778938600 @default.
• W3204388384 hasConceptScore W3204388384C502942594 @default.
• W3204388384 hasConceptScore W3204388384C530470458 @default.

• next